<DOC>
	<DOCNO>NCT00854997</DOCNO>
	<brief_summary>Objective : Untreated OSA associate three fold risk fetal non-fetal cardiovascular event control subject long-term follow . However , prevalence rate impact OSA patient acute myocardial infarction ( AMI ) clear far . The conflict study come variable period AMI , heart function enrollment , technique use diagnose OSA , time revascularization , target endpoint . Therefore , project aim study patient first-time , Killip I-II , post primary percutaneous coronary intervention ( PCI ) AMI chronic phase achieve four goal : Aim 1 . To determine prevalence rate OSA patient first-time AMI The acute phase AMI define within 14 day onset AMI chronic phase define &gt; 14 day onset . Eligible patient screen polysomnography within 5th 7th day 6th month AMI determine prevalence rate OSA AMI . Patients AHI 15/hr consider suffering OSA . Aim 2 . To identify clinical characteristic risk factor AMI patient associate OSA Patients follow clinic five year . The baseline demographic patient without OSA compare determine factor associate OSA AMI patient . Aim 3 . To study impact OSA prognosis AMI patient revascularizaton The primary endpoint mortality rate cardiac event . The secondary endpoint leave ventricular function variable relate cardiovascular disease ( CVD ) metabolic syndrome . The impact OSA AMI determine compare primary secondary endpoint AMI patient without OSA . Aim 4 . To identify clinical molecular factor attribute AMI OSA patient Factors attribute AMI OSA patient determine compare clinical data mRNA expression angiogenesis relate gene OSA patient acute phase AMI patient without major CVD .</brief_summary>
	<brief_title>The Impact Obstructive Sleep Apnea Outcomes Patients First-Time Acute Myocardial Infarction</brief_title>
	<detailed_description>Objectives : Obstructive sleep apnea ( OSA ) affect 4 % middle-aged men 2 % woman . Symptoms OSA include snore , unrefresh sleep , witness apnea , excessive daytime sleepiness hypertension . Untreated OSA patient associate three fold risk fetal non-fetal cardiovascular event control subject . However , prevalence rate impact OSA patient acute myocardial infarction ( AMI ) clear far . The conflict study come variable period AMI , heart function enrollment , technique use diagnose OSA , time revascularization , target endpoint . Therefore , project aim achieve four goal : ( 1 ) To determine prevalence rate OSA patient first-time AMI ( 2 ) To identify clinical characteristic risk factor AMI patient associate OSA ( 3 ) To study impact OSA prognosis AMI patient revascularization ( 4 ) To identify clinical molecular factor attribute AMI OSA patient Study design : Longitudinal , observational study Participants : AMI patient first-time , Killip I-II , post primary percutaneous coronary intervention ( PCI ) eligible study . Exclusion criterion include : refuse participate , require mechanical ventilation , active neurologic event , chronic pulmonary disease , active infection , need sedative narcotic within 3 day sleep study , participate study time . Protocol : Eligible patient screen polysomnography ( PSG ) within 5th 7th day onset AMI . Patients AHI 15/hr consider suffering OSA . Patients follow five year . The primary endpoint mortality rate cardiac event . The secondary endpoint leave ventricular function variable relate cardiovascular disease ( CVD ) metabolic syndrome . The acute phase AMI define within 14 day onset AMI chronic phase define &gt; 14 day onset . Statistic : The baseline demographic patient without OSA compare determine factor associate OSA AMI patient . The impact OSA AMI acute chronic phase determine compare mortality rate , incidence cardiac event , leave ventricular function , CVD risk factor , metabolic profile AMI patient without OSA . Factors attribute AMI OSA patient determine compare clinical data mRNA expression angiogenesis relate gene OSA patient acute phase AMI patient without major CVD . Clinical implication : Because prevalence rate OSA patient first-time AMI significant heart failure extremely high , early PSG screen identify factor associate OSA allow early diagnosis intervention . Understanding interaction OSA AMI help prevent morbidity mortality AMI patient . Also , allow prediction cardiovascular outcome early management OSA patient .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>firsttime , Killip III , post primary PCI within 5th 7th day AMI refuse participate , require mechanical ventilation , active neurologic event , chronic pulmonary disease , active infection , need sedative narcotic within 3 day sleep study , participate study time</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Obstructive sleep apnea ; myocardial infarction</keyword>
</DOC>